J&J Unit, NYU Sue Abbott Over Humira

By Amanda Ernst

Law360, New York (April 17, 2007, 12:00 AM ET) -- Johnson & Johnson subsidiary Centocor Inc. and New York University filed a patent infringement suit against Abbott Laboratories Monday over the drug maker’s flagship medication Humira.

In a complaint filed in the U.S. District Court for the Eastern District of Texas, Centocor and NYU claim that Humira, a tumor necrosis factor blocker, infringes on their patent, U.S. Patent Number 7,070,775.

According to Abbott, Humira is used to treat a variety of disorders, including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, a form of arthritis affecting the...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles